Use of antimigraine medication before pregnancy and in the first trimester: A cross‐sectional study
Most women with migraine used antimigraine medication before pregnancy, whereas usage decreased markedly in the first trimester. Only a few women had frequent use in the first trimester. Women with a short length of education of 1-2 years, additional chronic somatic diseases, or mental illness were more likely to report use of antimigraine medication. By offering an overview of patient-reported use of antimigraine medication before and during early pregnancy in a hospital-based setting, this study contributes to existing knowledge in the field and provides valuable insights for clinicians working with pregnant women affected by migraine.
Authors
- Ane Lilleøre Rom (ORCID: https://orcid.org/0000-0003-2474-2677)
- Mona Ameri Chalmer (ORCID: https://orcid.org/0000-0003-4609-1895)
- Mie Gaarskjær de Wolff (ORCID: https://orcid.org/0000-0002-9483-6559)
- Hanne Kristine Hegaard (ORCID: https://orcid.org/0000-0002-7093-0719)
- L. Buchgreitz
- Peter Damm (ORCID: https://orcid.org/0000-0002-2067-5246)
- L. Susan Wieland (ORCID: https://orcid.org/0000-0003-2157-0603)
- Marie Stampe Emborg
Institutions
- University of Copenhagen (DK)
- University of Southern Denmark (DK)
- Hvidovre Hospital (DK)
- Glostrup Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Region of Southern Denmark (DK)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1111/head.15010
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00